The AIRFoundry facility — funded by a six-year, $18 million National Science Foundation grant — brings together researchers ...
Announcing a new article publication for BIO Integration journal. Clinical trials bridge basic research and clinical application, serving as essential steps in drug development. This review examines ...
FDA moves shaping drug development and oversight include new gene therapy guidance, clinical trial transparency efforts, and recent drug approvals.
Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going ...
A drug developed at UB to treat FOXG1 syndrome has been cleared by the U.S. Food and Drug Administration to begin clinical trials. The agency approved an Investigational New Drug (IND) application for ...
The FDA’s new draft guidance on Bayesian methods in clinical trials has been hailed by some as a breakthrough that could speed drug development. But statisticians and researchers are divided on ...
Danish drugmaker Novo Nordisk, which has fallen behind Eli Lilly in the immensely lucrative weight-loss drug market, said ...
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results